Should the dose of RELPAX® be modified in patients with hepatic impairment?
No dose adjustment is required in patients with mild or moderate hepatic impairment.
RELPAX has not been studied in patients with severe hepatic impairment and is therefore contraindicated in these patients.
Tips and Tricks
Contact Pfizer Medical Information
Monday to Friday 9am – 5pm EST